Blood cancers, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at a drug called nivolumab for people with follicular lymphoma. It was for people whose lymphoma had come back or was no longer responding to treatment.
People could join the trial between 2014 and 2016. The team published the results in 2021.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 1 March 2014
Recruitment end: 6 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Johnson
Bristol-Myers Squibb
NIHR Clinical Research Network: Cancer
Last reviewed: 05 Oct 2026
CRUK internal database number: 11748
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
